ATE538779T1 - Menthol-enthaltendes präparat - Google Patents

Menthol-enthaltendes präparat

Info

Publication number
ATE538779T1
ATE538779T1 AT04746565T AT04746565T ATE538779T1 AT E538779 T1 ATE538779 T1 AT E538779T1 AT 04746565 T AT04746565 T AT 04746565T AT 04746565 T AT04746565 T AT 04746565T AT E538779 T1 ATE538779 T1 AT E538779T1
Authority
AT
Austria
Prior art keywords
menthol
formulation
digestive tract
contraction
long time
Prior art date
Application number
AT04746565T
Other languages
English (en)
Inventor
Tomonori Hamawaki
Yosuke Kataoka
Takako Isoda
Original Assignee
Nihon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Pharmaceutical Co Ltd filed Critical Nihon Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE538779T1 publication Critical patent/ATE538779T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/273—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the upper alimentary canal, e.g. oesophagoscopes or gastroscopes
    • A61B1/2736—Gastroscopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/31—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the rectum, e.g. proctoscopes or sigmoidoscopes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04746565T 2003-06-30 2004-06-28 Menthol-enthaltendes präparat ATE538779T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003186493 2003-06-30
PCT/JP2004/009096 WO2005000361A1 (ja) 2003-06-30 2004-06-28 メントール含有製剤

Publications (1)

Publication Number Publication Date
ATE538779T1 true ATE538779T1 (de) 2012-01-15

Family

ID=33549692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04746565T ATE538779T1 (de) 2003-06-30 2004-06-28 Menthol-enthaltendes präparat

Country Status (8)

Country Link
US (2) US20060121067A1 (de)
EP (2) EP2311444B1 (de)
JP (1) JP4459167B2 (de)
KR (1) KR100985131B1 (de)
CN (2) CN102038963B (de)
AT (1) ATE538779T1 (de)
ES (2) ES2379876T3 (de)
WO (1) WO2005000361A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10441766B2 (en) * 2007-08-08 2019-10-15 Given Imaging Ltd. Method for clearing a body lumen environment
US20090275795A1 (en) * 2008-05-02 2009-11-05 Zassi Medical Evolutions, Inc. Continent ostomy system with chemical neuromuscular control
JP6552414B2 (ja) * 2013-02-01 2019-07-31 ディードロップス カンパニー 液体メントール組成物
CN116370442A (zh) * 2017-11-01 2023-07-04 武田药品工业株式会社 药物组合物、药物组合物的稳定化方法、以及评价药物组合物的保存稳定性的方法
CN108143717A (zh) * 2018-02-12 2018-06-12 周基清 一种薄荷脑纳米乳剂及其制备方法
CN109011720B (zh) * 2018-08-27 2020-10-02 南通市晗泰化工有限公司 一种污水处理用高效消泡剂及其制备方法和应用
CN110327471B (zh) * 2019-01-24 2021-08-27 奥纳斯(北京)医药科技有限公司 一种内镜检查解痉消泡剂及其制备方法
CN110200906B (zh) * 2019-07-25 2021-07-20 奥纳斯(北京)医药科技有限公司 一种l-薄荷醇水溶液及其制备方法
US11622944B2 (en) 2020-01-31 2023-04-11 Babak Ghalili Stabilized menthol and other volatile compound compositions and methods
CN117883380B (zh) * 2023-12-18 2025-04-01 首都医科大学附属北京同仁医院 一种用于治疗干眼症的经皮给药的乳剂
WO2025220027A1 (en) * 2024-04-19 2025-10-23 Anikhindi Dr Shrihari A combination liquid solution for pre-endoscopy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422189A (en) * 1959-01-02 1969-01-14 Moraine Products Method and compositions for the treatment of gastro-intestinal disorders
GB2006011B (en) * 1977-08-04 1982-04-21 Rhodes J Carminative preparations containing essential oila their active components
IT1243439B (it) * 1990-10-10 1994-06-10 Pulitzer Italiana Derivato di mentolo ad azione spasmolitica
JP3286350B2 (ja) * 1992-08-07 2002-05-27 花王株式会社 透明水性組成物
JPH11506769A (ja) * 1995-06-05 1999-06-15 ホワイトヒル・オーラル・テクノロジー・インコーポレイテツド 口腔用ウルトラマルジョンを主成分とする製品
JP3524717B2 (ja) * 1997-06-13 2004-05-10 株式会社資生堂 油中水型乳化組成物及びこれを用いた乳化化粧料
US6428814B1 (en) * 1999-10-08 2002-08-06 Elan Pharma International Ltd. Bioadhesive nanoparticulate compositions having cationic surface stabilizers
AU2002343555A1 (en) * 2001-11-14 2003-05-26 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
JP2003292450A (ja) * 2002-02-01 2003-10-15 Naoki Hiki 胃蠕動抑制剤
WO2003097026A1 (en) * 2002-05-22 2003-11-27 Nihon Pharmaceutical Co., Ltd. Smooth muscle peristole inhibitor
JP4526120B2 (ja) * 2002-05-22 2010-08-18 日本製薬株式会社 Ｌ−メントール水中油型乳剤
US6897195B2 (en) * 2002-07-24 2005-05-24 Nanjing Zhongshi Chemical Co. Composition of menthol and menthyl lactate, its preparation method and its applications as a cooling agent

Also Published As

Publication number Publication date
US20090292028A1 (en) 2009-11-26
KR100985131B1 (ko) 2010-10-05
US7993635B2 (en) 2011-08-09
CN102038963B (zh) 2013-09-11
ES2390162T3 (es) 2012-11-07
ES2379876T3 (es) 2012-05-04
EP1640022B1 (de) 2011-12-28
EP1640022A4 (de) 2008-08-06
EP2311444B1 (de) 2012-06-27
CN102038963A (zh) 2011-05-04
JPWO2005000361A1 (ja) 2006-10-19
JP4459167B2 (ja) 2010-04-28
HK1098683A1 (en) 2007-07-27
EP1640022A1 (de) 2006-03-29
CN1893982A (zh) 2007-01-10
HK1155640A1 (en) 2012-05-25
WO2005000361A1 (ja) 2005-01-06
KR20060032604A (ko) 2006-04-17
EP2311444A1 (de) 2011-04-20
US20060121067A1 (en) 2006-06-08
CN1893982B (zh) 2013-02-13

Similar Documents

Publication Publication Date Title
Sirak et al. Clinical and morphological substantiation of treatment of odontogenic cysts of the maxilla
EP1640022A4 (de) Menthol-enthaltendes präparat
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
WO2006094737A8 (en) Gastroresistant pharmaceutical formulations containing rifaximin
WO2007084247A3 (en) Stable therapeutic formulations
WO2009048945A8 (en) Rapid mucosal gel or film insulin compositions
EP4309722A3 (de) Einnehmbare vorrichtung zur abgabe eines therapeutischen mittels an den magen-darm-trakt
WO2009010968A3 (en) Disease treatment via antimicrobial peptides or their inhibitors
AU2015213577A2 (en) Halogen treatment of heart attack and ischemic injury
WO2008157369A3 (en) Use of taci-ig fusion protein such as atacicept for the manufacture of a medicament for treating lupus erythematosus
WO2006081363A3 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
SE0402925D0 (sv) Novel Compounds
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
WO2019070850A1 (en) LOCAL ADMINISTRATION OF ANINEOPLASTIC PARTICLES IN COMBINATION WITH SYSTEMIC DELIVERY OF IMMUNOTHERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER
Moraes et al. Liquid nitrogen cryosurgery for treatment of mucoceles in children
ITMI20022777A1 (it) Formulazioni farmaceutiche per ormoni tiroidei e procedimenti per il loro ottenimento.
EP3570847A1 (de) Zusammensetzungen zur polypanhebung und verfahren zur verwendung
de Souza et al. Intratablet S-nitrosation: a new approach for the oral administration of S-nitrosothiols as nitric oxide donors
RU2016127361A (ru) Гастроретентивные фармацевтические композиции для перорального введения
ITTO20130375A1 (it) Prodotto per l'uso per il trattamento terapeutico di parodontopatie e perimplantiti
Koizumi et al. Angiomyolipoma of the tongue
ES2750632T3 (es) Utilización de un extracto particular de propóleo para luchar contra los efectos secundarios de quimioterapias
Timio et al. Patients with Renal Disease: From Poetry to Evidence Based Medicine. Is there a Place for Bioethics?
Amal Gynaecological disturbances among females engaged in the manufacture of sex hormones
RU2017134594A (ru) Фармацевтическая композиция, включающая полипептид